Perpetua Medical AB (publ) (STO:PERP.B)

Market Cap	21.66M
Revenue (ttm)	6.94M
Net Income (ttm)	-2.47M
Shares Out	4.52M
EPS (ttm)	-0.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,479
Average Volume	2,896
Open	4.500
Previous Close	4.600
Day's Range	4.430 - 4.790
52-Week Range	0.965 - 5.410
Beta	2.41
RSI	45.89
Earnings Date	Apr 25, 2025

About Perpetua Medical AB

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024....

• Industry: Laboratory Analytical Instruments
• Founded: 2007
• Employees: 3
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PERP.B

Financial Performance

In 2024, Perpetua Medical AB's revenue was 6.94 million, a decrease of -30.16% compared to the previous year's 9.94 million. Losses were -2.47 million, -86.47% less than in 2023.